Benjamin Terrier Selected Research

Purpura

1/2022	Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry.
5/2021	New insights on IgA vasculitis with underlying solid tumor: a nationwide French study of 30 patients.
1/2021	Impact of aging on phenotype and prognosis in IgA vasculitis.
6/2020	International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis.
1/2020	Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management.
1/2016	Efficacy of colchicine in a child with relapsing bullous Henoch-Schönlein purpura.
7/2015	IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects.
12/2010	Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinaemia vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin Terrier Research Topics

Disease

60	Vasculitis (Vasculitides) 04/2022 - 12/2007
29	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2022 - 11/2015
25	COVID-19 11/2022 - 01/2020
23	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 08/2022 - 05/2014
19	Infections 04/2022 - 01/2007
16	Microscopic Polyangiitis 01/2022 - 09/2014
11	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021 - 11/2010
9	Inflammation (Inflammations) 01/2022 - 11/2015
8	Purpura 01/2022 - 12/2010
7	Glomerulonephritis 10/2022 - 03/2013
7	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2022 - 02/2009
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2007
6	Systemic Vasculitis 11/2022 - 12/2010
6	Cryoglobulinemia 04/2022 - 07/2010
6	Hemorrhage 05/2021 - 12/2015
6	Asthma (Bronchial Asthma) 01/2021 - 01/2016
6	Mononeuropathies (Mononeuritis Multiplex) 10/2020 - 12/2007
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 08/2010
5	IgA Vasculitis (Purpura, Schoenlein Henoch) 05/2022 - 07/2015
5	Systemic Scleroderma (Systemic Sclerosis) 04/2022 - 05/2008
5	Lymphoma (Lymphomas) 01/2022 - 02/2007
5	Giant Cell Arteritis (Horton Disease) 03/2021 - 06/2012
4	Cardiomyopathies (Cardiomyopathy) 01/2022 - 02/2013
4	Neoplasms (Cancer) 01/2022 - 09/2020
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 06/2013
4	Arthralgia (Joint Pain) 01/2022 - 01/2011
4	Immunoglobulin G4-Related Disease 01/2018 - 01/2013
4	Virus Diseases (Viral Diseases) 05/2015 - 02/2009
4	Chronic Hepatitis C 05/2015 - 01/2011
3	Fibrosis (Cirrhosis) 04/2022 - 10/2011
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2014
3	Sarcoidosis (Schaumann Disease) 04/2020 - 11/2014
3	Necrosis 01/2018 - 03/2013
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2014 - 12/2010
2	Uveitis 08/2022 - 04/2020
2	Meningitis 01/2022 - 01/2018
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2018
2	Pathologic Constriction (Stenosis) 01/2022 - 08/2015
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 05/2020
2	Behcet Syndrome (Behcet's Syndrome) 01/2022 - 09/2011
2	VEXAS syndrome 01/2022 - 10/2021
2	Melanoma (Melanoma, Malignant) 12/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

43	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 10/2012
29	Rituximab (Mabthera)FDA Link 10/2022 - 02/2007
19	AntibodiesIBA 04/2022 - 01/2007
18	GlucocorticoidsIBA 10/2022 - 05/2014
15	Biological ProductsIBA 05/2021 - 12/2006
13	Immunosuppressive Agents (Immunosuppressants)IBA 08/2022 - 06/2011
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2010
9	Antiviral Agents (Antivirals)IBA 01/2021 - 02/2009
8	CytokinesIBA 05/2022 - 12/2006
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 12/2006
6	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2009
6	Immunoglobulin A (IgA)IBA 11/2021 - 07/2015
6	InterferonsIBA 10/2021 - 01/2011
5	AutoantibodiesIBA 04/2022 - 10/2012
5	CreatinineIBA 01/2022 - 11/2011
5	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 01/2011
5	AntigensIBA 01/2021 - 05/2008
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2014
5	Vitamin D FDA LinkGeneric 04/2020 - 10/2011
5	Azathioprine (Imuran)FDA LinkGeneric 03/2019 - 03/2016
5	Ribavirin (Virazole)FDA LinkGeneric 05/2015 - 08/2009
4	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2020
4	Peroxidase (Myeloperoxidase)IBA 01/2022 - 01/2019
4	Immunoglobulin G (IgG)IBA 11/2021 - 01/2018
4	Monoclonal AntibodiesIBA 01/2021 - 01/2013
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 01/2011
3	Oxygen (Dioxygen)IBA 01/2022 - 05/2020
3	Interferon Type IIBA 01/2022 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2020
3	Immunomodulating AgentsIBA 01/2021 - 09/2014
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 04/2013
3	hydroxide ionIBA 04/2020 - 10/2011
3	Myeloblastin (Proteinase 3)IBA 01/2019 - 11/2015
3	SteroidsIBA 11/2017 - 08/2007
3	Interferon-alpha (Interferon Alfa)IBA 05/2015 - 07/2010
3	Rheumatoid FactorIBA 03/2015 - 12/2007
3	interleukin-21 (interleukin 21)IBA 09/2012 - 09/2011
2	COVID-19 VaccinesIBA 10/2022 - 07/2022
2	BNT162 VaccineIBA 07/2022 - 08/2021
2	Alkylating AgentsIBA 04/2022 - 03/2013
2	belimumabIBA 04/2022 - 01/2013
2	Interleukin-1 (Interleukin 1)IBA 01/2022 - 10/2019
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2021
2	Colchicine FDA LinkGeneric 01/2022 - 01/2016
2	baricitinibIBA 01/2022 - 11/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 10/2020
2	EnzymesIBA 01/2022 - 10/2021
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 03/2016
2	Immunoglobulin M (IgM)IBA 11/2021 - 03/2008
2	C-Reactive ProteinIBA 11/2021 - 12/2007

Therapy/Procedure

43	Therapeutics 10/2022 - 12/2006
7	Plasma Exchange 10/2022 - 12/2015
6	Remission Induction 10/2020 - 05/2014
3	Immunomodulation 01/2022 - 01/2021
3	Aftercare (After-Treatment) 01/2021 - 12/2010
2	Immunotherapy 01/2022 - 02/2014